CNE100000W45
CNE100000W45
JOINTOWN PHARMACEUTICAL GROUP C
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 25.62B EUR | 23.65B EUR | 26.62B EUR | 25.82B EUR |
Enterprise Value | 33.77B EUR | 20.86B EUR | 26.39B EUR | 22.09B EUR |
Valuation Multiples | ||||
Trailing P/E | 13.37x | 15.98x | 17.89x | 14.97x |
Forward P/E | 11.8x | -- | -- | -- |
Price to Sales | 0.15x | 0.18x | 0.21x | 0.21x |
Price to Book | 0.98x | 0.82x | 0.91x | 0.9x |
EV/Revenue | 0.2x | 0.16x | 0.21x | 0.18x |
EV/EBITDA | 8.35x | 6.34x | 8.15x | 5.37x |
Price to FCF (P/FCF) | 14.3x | 11.56x | 12.05x | 14.22x |
EV/FCF | 18.85x | 10.2x | 11.94x | 12.17x |
FCF Yield | 6.99% | 8.65% | 8.3% | 7.03% |